NASDAQ: BCRX

Biocryst Pharmaceuticals Inc (BCRX) EPS is poised to hit 0.04 next quarter: How Investors Can Make It Count the Most?
Steve Mayer
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) open the trading on Wednesday, with great promise as it jumped 4.75% to $7.28, before ...